Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight

8 Jun 2024

Abstract excerpt

Epigenetic and metabolic reprogramming alterations are two important features of tumors, and their reversible, spatial, and temporal regulation is a distinctive hallmark of carcinogenesis. Epigenetics, which focuses on gene regulatory mechanisms beyond the DNA sequence, is a new entry point for tumor therapy. Moreover, metabolic reprogramming drives hepatocellular carcinoma (HCC) initiation and progression,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Liver Disease Diagnosis and Treatment
Share to Peroxisome Proliferator-Activated Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38921460
DOI: 10.3390/metabo14060325

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New SightPMID 38921460Read ↗

Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver CancerSemantic proximity Read ↗

Metabolic Reprogramming of HCC: A New Microenvironment for Immune ResponsesSemantic proximity Read ↗

Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma.Semantic proximity Read ↗

Linking metabolism and epigenetic regulation in development of hepatocellular carcinomaSemantic proximity Read ↗

Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic StrategiesSemantic proximity Read ↗

Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A reviewSemantic proximity Read ↗

Metabolic reprogramming and its clinical implication for liver cancerSemantic proximity Read ↗

Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor ProgressionSemantic proximity Read ↗

The Influence of Epigenetic Mechanisms on the Development of Metabolic Dysfunction Associated Steatotic Liver Disease: A Review.Semantic proximity Read ↗

Role of genetic variants and DNA methylation of lipid metabolism-related genes in metabolic dysfunction-associated steatotic liver diseaseSemantic proximity Read ↗

The Interplay between Dysregulated Metabolism and Epigenetics in CancerSemantic proximity Read ↗

Clinical and pathological characteristics of metabolic dysfunction-associated steatotic liver disease and the key role of epigenetic regulation: implications for molecular mechanism and treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.